Skip to main content

Table 4 Univariate Cox analysis for predicting primary endpoint during the follow-up

From: CMR Characteristics, gene variants and long-term outcome in patients with left ventricular non-compaction cardiomyopathy

Parameters

LR χ2 (p value)

Wald

HR (95% CI)

p value

Age

7.627 (0.006)

6.759

1.064 (1.015–1.115)

0.006

Sex

0.427 (0.513)

0.418

0.599 (0.126–2.835)

0.518

Body surface area

0.359 (0.549)

0.357

0.436 (0.029–6.637)

0.550

Genotype status

1.202 (0.273)

1.158

1.982 (0.570–6.887)

0.282

LV-C

5.028 (0.025)

4.740

1.699 (1.054–2.739)

0.029

LV-NC/C

0.231 (0.631)

0.229

1.208 (0.557–2.618)

0.632

LVMi-C

8.532 (0.003)

7.571

1.049 (1.014–1.086)

0.006

LVMi-MM

11.950 (0.001)

9.987

1.025 (1.009–1.041)

0.002

LGE

4.726 (0.030)

4.267

1.056 (1.003–1.112)

0.039

LVEF

12.523 (< 0.001)

9.309

0.910 (0.859–0.967)

0.002

LVEDVi

8.035 (0.005)

6.999

1.011 (1.003–1.019)

0.008

Vmax

11.271 (0.001)

8.706

1.023 (1.008–1.038)

0.003

Vpre-a

11.560 (0.001)

8.858

1.024 (1.008–1.040)

0.003

Vmin

10.092 (0.001)

7.875

1.024 (1.007–1.040)

0.005

εs

5.806 (0.016)

4.976

0.930 (0.872–0.991)

0.026

εe

6.158 (0.013)

5.548

0.900 (0.824–0.982)

0.019

εa

2.986 (0.084)

2.736

0.944 (0.882–1.011)

0.098

GLS

7.223 (0.007)

0.007

1.195 (1.044–1.368)

0.010

GCS

10.984 (0.001)

7.72

1.187 (1.052–1.339)

0.005

GRS

5.874 (0.015)

5.189

0.951 (0.911–0.993)

0.023

  1. Abbreviation as in Table 2